Medications

Encouraging findings for Batten disease drug

The FDA-approved, lipid-lowering medication gemfibrozil may prevent the progression of juvenile Batten disease, according to researchers at RUSH. Results from the study were recently published in The Journal of Neuroscience.

Diseases, Conditions, Syndromes

Discovery of a potential therapeutic target for ALS

University of Malta researchers have discovered a potential new drug target for amyotrophic lateral sclerosis (ALS), according to a new study published in the Neurobiology of Aging journal.

Pediatrics

Febrile urinary tract infections common with neurogenic bladder

Recurrent febrile urinary tract infections (FUTIs) are common in children with neurogenic bladder, and the risk for rapid progression to chronic kidney disease (CKD) increases in a dose-response manner, according to a study ...

Diseases, Conditions, Syndromes

Targeting type of B cell could reduce lupus disease, study suggests

A group of University of Pittsburgh researchers has given new meaning to "knowing your ABCs." In a new study, published in the Journal of Experimental Medicine, the team showed that a type of immune cell called age-associated ...

Parkinson's & Movement disorders

New study details inflammation in early stages of Parkinson's disease

New research by investigators at the University of Alabama at Birmingham supports the premise that inflammation is associated with Parkinson's disease early in the disease's progression. The findings, published online in ...

page 14 from 40